Show simple item record

dc.contributor.authorSaldana-Guerrero, IM
dc.contributor.authorMontano-Gutierrez, LF
dc.contributor.authorBoswell, K
dc.contributor.authorHafemeister, C
dc.contributor.authorPoon, E
dc.contributor.authorShaw, LE
dc.contributor.authorStavish, D
dc.contributor.authorLea, RA
dc.contributor.authorWernig-Zorc, S
dc.contributor.authorBozsaky, E
dc.contributor.authorFetahu, IS
dc.contributor.authorZoescher, P
dc.contributor.authorPötschger, U
dc.contributor.authorBernkopf, M
dc.contributor.authorWenninger-Weinzierl, A
dc.contributor.authorSturtzel, C
dc.contributor.authorSouilhol, C
dc.contributor.authorTarelli, S
dc.contributor.authorShoeb, MR
dc.contributor.authorBozatzi, P
dc.contributor.authorRados, M
dc.contributor.authorGuarini, M
dc.contributor.authorBuri, MC
dc.contributor.authorWeninger, W
dc.contributor.authorPutz, EM
dc.contributor.authorHuang, M
dc.contributor.authorLadenstein, R
dc.contributor.authorAndrews, PW
dc.contributor.authorBarbaric, I
dc.contributor.authorCresswell, GD
dc.contributor.authorBryant, HE
dc.contributor.authorDistel, M
dc.contributor.authorChesler, L
dc.contributor.authorTaschner-Mandl, S
dc.contributor.authorFarlik, M
dc.contributor.authorTsakiridis, A
dc.contributor.authorHalbritter, F
dc.coverage.spatialEngland
dc.date.accessioned2024-07-30T13:57:11Z
dc.date.available2024-07-30T13:57:11Z
dc.date.issued2024-05-03
dc.identifierARTN 3745
dc.identifier10.1038/s41467-024-47945-7
dc.identifier.citationNature Communications, 2024, 15 (1), pp. 3745 -en_US
dc.identifier.issn2041-1723
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/6321
dc.identifier.eissn2041-1723
dc.identifier.eissn2041-1723
dc.identifier.doi10.1038/s41467-024-47945-7
dc.identifier.doi10.1038/s41467-024-47945-7
dc.description.abstractEarly childhood tumours arise from transformed embryonic cells, which often carry large copy number alterations (CNA). However, it remains unclear how CNAs contribute to embryonic tumourigenesis due to a lack of suitable models. Here we employ female human embryonic stem cell (hESC) differentiation and single-cell transcriptome and epigenome analysis to assess the effects of chromosome 17q/1q gains, which are prevalent in the embryonal tumour neuroblastoma (NB). We show that CNAs impair the specification of trunk neural crest (NC) cells and their sympathoadrenal derivatives, the putative cells-of-origin of NB. This effect is exacerbated upon overexpression of MYCN, whose amplification co-occurs with CNAs in NB. Moreover, CNAs potentiate the pro-tumourigenic effects of MYCN and mutant NC cells resemble NB cells in tumours. These changes correlate with a stepwise aberration of developmental transcription factor networks. Together, our results sketch a mechanistic framework for the CNA-driven initiation of embryonal tumours.
dc.formatElectronic
dc.format.extent3745 -
dc.languageeng
dc.language.isoengen_US
dc.publisherNATURE PORTFOLIOen_US
dc.relation.ispartofNature Communications
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.subjectHumans
dc.subjectNeuroblastoma
dc.subjectNeural Crest
dc.subjectFemale
dc.subjectDNA Copy Number Variations
dc.subjectCell Differentiation
dc.subjectN-Myc Proto-Oncogene Protein
dc.subjectChromosome Aberrations
dc.subjectHuman Embryonic Stem Cells
dc.subjectTranscriptome
dc.subjectCell Line, Tumor
dc.subjectGene Expression Regulation, Neoplastic
dc.titleA human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.en_US
dc.typeJournal Article
dcterms.dateAccepted2024-04-15
dc.date.updated2024-07-30T13:56:00Z
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1038/s41467-024-47945-7en_US
rioxxterms.licenseref.startdate2024-05-03
rioxxterms.typeJournal Article/Reviewen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38702304
pubs.issue1
pubs.organisational-groupICR
pubs.organisational-groupICR/Primary Group
pubs.organisational-groupICR/Primary Group/ICR Divisions
pubs.organisational-groupICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-groupICR/Primary Group/ICR Divisions/Cancer Therapeutics/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-groupICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-groupICR/Primary Group/ICR Divisions/Clinical Studies/Paediatric Solid Tumour Biology and Therapeutics
pubs.organisational-groupICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-groupICR/Primary Group/ICR Divisions/Molecular Pathology/Paediatric Solid Tumour Biology and Therapeutics
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.1038/s41467-024-47945-7
pubs.volume15
icr.researchteamPaediatric Tumour Biologyen_US
dc.contributor.icrauthorPoon, Evon
dc.contributor.icrauthorChesler, Louis
icr.provenanceDeposited by Mr Arek Surman on 2024-07-30. Deposit type is initial. No. of files: 1. Files: s41467-024-47945-7.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/